annual SGA:
$1.01B+$119.60M(+13.47%)Summary
- As of today (May 29, 2025), NBIX annual SGA is $1.01 billion, with the most recent change of +$119.60 million (+13.47%) on December 31, 2024.
- During the last 3 years, NBIX annual SGA has risen by +$423.90 million (+72.67%).
- NBIX annual SGA is now at all-time high.
Performance
NBIX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$276.50M-$11.30M(-3.93%)Summary
- As of today (May 29, 2025), NBIX quarterly SGA is $276.50 million, with the most recent change of -$11.30 million (-3.93%) on March 31, 2025.
- Over the past year, NBIX quarterly SGA has increased by +$33.40 million (+13.74%).
- NBIX quarterly SGA is now -3.93% below its all-time high of $287.80 million, reached on December 31, 2024.
Performance
NBIX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$56.30M+$108.40M(+208.06%)Summary
- As of today (May 29, 2025), NBIX TTM SGA is $56.30 million, with the most recent change of +$108.40 million (+208.06%) on March 31, 2025.
- Over the past year, NBIX TTM SGA has dropped by -$831.70 million (-93.66%).
- NBIX TTM SGA is now at all-time high.
Performance
NBIX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NBIX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.5% | +13.7% | -93.7% |
| 3 y3 years | +72.7% | +37.8% | -91.4% |
| 5 y5 years | +184.4% | +134.7% | -85.3% |
NBIX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.7% | -3.9% | +51.3% | at high | +102.3% |
| 5 y | 5-year | at high | +184.4% | -3.9% | +186.5% | at high | +101.2% |
| alltime | all time | at high | >+9999.0% | -3.9% | >+9999.0% | at high | +101.2% |
NBIX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $276.50M(-3.9%) | $1.04B(+3.3%) |
| Dec 2024 | $1.01B(+13.5%) | $287.80M(+22.8%) | $1.01B(+7.3%) |
| Sep 2024 | - | $234.30M(-3.2%) | $938.30M(+3.3%) |
| Jun 2024 | - | $242.00M(-0.5%) | $908.20M(+2.3%) |
| Mar 2024 | - | $243.10M(+11.1%) | $888.00M(+0.0%) |
| Dec 2023 | $887.60M(+17.9%) | $218.90M(+7.2%) | $887.60M(+4.2%) |
| Sep 2023 | - | $204.20M(-7.9%) | $851.60M(+2.1%) |
| Jun 2023 | - | $221.80M(-8.6%) | $833.70M(+4.9%) |
| Mar 2023 | - | $242.70M(+32.7%) | $794.70M(+5.6%) |
| Dec 2022 | $752.70M(+29.0%) | $182.90M(-1.8%) | $752.70M(+3.6%) |
| Sep 2022 | - | $186.30M(+1.9%) | $726.30M(+4.6%) |
| Jun 2022 | - | $182.80M(-8.9%) | $694.60M(+6.0%) |
| Mar 2022 | - | $200.70M(+28.2%) | $655.00M(+12.3%) |
| Dec 2021 | $583.30M(+34.6%) | $156.50M(+1.2%) | $583.30M(+9.4%) |
| Sep 2021 | - | $154.60M(+8.0%) | $533.30M(+8.6%) |
| Jun 2021 | - | $143.20M(+11.0%) | $491.20M(+10.5%) |
| Mar 2021 | - | $129.00M(+21.1%) | $444.50M(+2.6%) |
| Dec 2020 | $433.30M(+22.4%) | $106.50M(-5.3%) | $433.30M(+1.2%) |
| Sep 2020 | - | $112.50M(+16.6%) | $428.10M(+7.0%) |
| Jun 2020 | - | $96.50M(-18.1%) | $400.10M(+4.1%) |
| Mar 2020 | - | $117.80M(+16.3%) | $384.40M(+8.6%) |
| Dec 2019 | $354.10M(+42.3%) | $101.30M(+19.9%) | $354.10M(+10.1%) |
| Sep 2019 | - | $84.50M(+4.6%) | $321.75M(+8.1%) |
| Jun 2019 | - | $80.80M(-7.7%) | $297.65M(+7.2%) |
| Mar 2019 | - | $87.50M(+26.9%) | $277.76M(+11.6%) |
| Dec 2018 | $248.90M(+46.5%) | $68.95M(+14.2%) | $248.90M(+5.3%) |
| Sep 2018 | - | $60.40M(-0.8%) | $236.26M(+7.5%) |
| Jun 2018 | - | $60.91M(+3.9%) | $219.73M(+9.6%) |
| Mar 2018 | - | $58.64M(+4.1%) | $200.49M(+18.0%) |
| Dec 2017 | $169.91M(+149.6%) | $56.31M(+28.3%) | $169.91M(+23.8%) |
| Sep 2017 | - | $43.87M(+5.3%) | $137.26M(+23.8%) |
| Jun 2017 | - | $41.67M(+48.6%) | $110.89M(+31.7%) |
| Mar 2017 | - | $28.05M(+18.5%) | $84.18M(+23.6%) |
| Dec 2016 | $68.08M(+109.6%) | $23.67M(+35.3%) | $68.08M(+27.6%) |
| Sep 2016 | - | $17.49M(+16.9%) | $53.35M(+12.8%) |
| Jun 2016 | - | $14.96M(+25.2%) | $47.31M(+21.5%) |
| Mar 2016 | - | $11.95M(+33.7%) | $38.95M(+19.9%) |
| Dec 2015 | $32.48M(+80.6%) | $8.94M(-22.0%) | $32.48M(+13.9%) |
| Sep 2015 | - | $11.46M(+73.5%) | $28.51M(+31.3%) |
| Jun 2015 | - | $6.60M(+20.4%) | $21.72M(+12.4%) |
| Mar 2015 | - | $5.48M(+10.3%) | $19.32M(+7.4%) |
| Dec 2014 | $17.99M(+34.7%) | $4.97M(+6.6%) | $17.99M(+10.0%) |
| Sep 2014 | - | $4.66M(+11.0%) | $16.36M(+9.5%) |
| Jun 2014 | - | $4.20M(+1.1%) | $14.94M(+5.9%) |
| Mar 2014 | - | $4.15M(+24.3%) | $14.11M(+5.7%) |
| Dec 2013 | $13.35M(-0.7%) | $3.34M(+3.0%) | $13.35M(+0.2%) |
| Sep 2013 | - | $3.25M(-3.7%) | $13.32M(-0.6%) |
| Jun 2013 | - | $3.37M(-0.6%) | $13.40M(+1.8%) |
| Mar 2013 | - | $3.39M(+2.4%) | $13.16M(-2.1%) |
| Dec 2012 | $13.44M(+7.9%) | $3.31M(-0.4%) | $13.44M(+5.8%) |
| Sep 2012 | - | $3.32M(+6.2%) | $12.71M(-3.2%) |
| Jun 2012 | - | $3.13M(-14.7%) | $13.12M(+1.9%) |
| Mar 2012 | - | $3.67M(+42.3%) | $12.87M(+3.3%) |
| Dec 2011 | $12.46M(-6.1%) | $2.58M(-31.0%) | $12.46M(-2.7%) |
| Sep 2011 | - | $3.74M(+29.6%) | $12.80M(-0.1%) |
| Jun 2011 | - | $2.88M(-11.4%) | $12.82M(-2.8%) |
| Mar 2011 | - | $3.26M(+11.4%) | $13.18M(-0.7%) |
| Dec 2010 | $13.27M | $2.92M(-22.2%) | $13.27M(-29.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $3.75M(+15.5%) | $18.71M(+4.4%) |
| Jun 2010 | - | $3.25M(-2.9%) | $17.92M(-8.1%) |
| Mar 2010 | - | $3.35M(-60.0%) | $19.50M(-4.2%) |
| Dec 2009 | $20.34M(-39.6%) | $8.36M(+181.7%) | $20.34M(-30.4%) |
| Sep 2009 | - | $2.97M(-38.6%) | $29.24M(-1.7%) |
| Jun 2009 | - | $4.83M(+15.1%) | $29.75M(+0.5%) |
| Mar 2009 | - | $4.20M(-75.7%) | $29.59M(-12.1%) |
| Dec 2008 | $33.68M(-10.1%) | $17.25M(+397.0%) | $33.68M(+23.8%) |
| Sep 2008 | - | $3.47M(-25.6%) | $27.21M(-18.3%) |
| Jun 2008 | - | $4.67M(-43.7%) | $33.31M(-11.1%) |
| Mar 2008 | - | $8.29M(-23.2%) | $37.45M(-0.1%) |
| Dec 2007 | $37.48M(-31.7%) | $10.79M(+12.7%) | $37.48M(+10.9%) |
| Sep 2007 | - | $9.57M(+8.7%) | $33.79M(-16.1%) |
| Jun 2007 | - | $8.81M(+5.9%) | $40.27M(-8.2%) |
| Mar 2007 | - | $8.32M(+17.2%) | $43.85M(-20.1%) |
| Dec 2006 | $54.87M(+29.6%) | $7.09M(-55.8%) | $54.87M(-11.1%) |
| Sep 2006 | - | $16.05M(+29.5%) | $61.72M(+5.2%) |
| Jun 2006 | - | $12.40M(-35.9%) | $58.67M(+4.7%) |
| Mar 2006 | - | $19.34M(+38.7%) | $56.06M(+32.4%) |
| Dec 2005 | $42.33M(+88.6%) | $13.94M(+7.3%) | $42.33M(+22.1%) |
| Sep 2005 | - | $13.00M(+32.8%) | $34.66M(+27.9%) |
| Jun 2005 | - | $9.79M(+74.5%) | $27.09M(+19.0%) |
| Mar 2005 | - | $5.61M(-10.5%) | $22.77M(+1.4%) |
| Dec 2004 | $22.44M(+9.0%) | $6.26M(+15.4%) | $22.44M(+3.9%) |
| Sep 2004 | - | $5.43M(-0.8%) | $21.60M(+0.6%) |
| Jun 2004 | - | $5.47M(+3.5%) | $21.47M(+1.6%) |
| Mar 2004 | - | $5.28M(-2.5%) | $21.13M(+2.6%) |
| Dec 2003 | $20.59M(+61.9%) | $5.42M(+2.3%) | $20.59M(+9.8%) |
| Sep 2003 | - | $5.30M(+3.1%) | $18.76M(+12.2%) |
| Jun 2003 | - | $5.13M(+8.2%) | $16.72M(+13.5%) |
| Mar 2003 | - | $4.74M(+32.3%) | $14.73M(+15.8%) |
| Dec 2002 | $12.72M(+17.2%) | $3.59M(+10.2%) | $12.72M(+0.3%) |
| Sep 2002 | - | $3.25M(+3.2%) | $12.69M(+10.3%) |
| Jun 2002 | - | $3.15M(+15.4%) | $11.51M(+2.6%) |
| Mar 2002 | - | $2.73M(-23.1%) | $11.21M(+3.3%) |
| Dec 2001 | $10.86M(+9.0%) | $3.55M(+71.4%) | $10.86M(+5.0%) |
| Sep 2001 | - | $2.07M(-27.4%) | $10.34M(-4.0%) |
| Jun 2001 | - | $2.85M(+20.1%) | $10.77M(+6.6%) |
| Mar 2001 | - | $2.38M(-21.6%) | $10.11M(+1.4%) |
| Dec 2000 | $9.96M(+32.8%) | $3.03M(+20.8%) | $9.96M(+12.8%) |
| Sep 2000 | - | $2.51M(+14.7%) | $8.83M(+7.4%) |
| Jun 2000 | - | $2.19M(-2.0%) | $8.22M(+2.3%) |
| Mar 2000 | - | $2.23M(+17.5%) | $8.03M(+7.1%) |
| Dec 1999 | $7.50M(+13.6%) | $1.90M(0.0%) | $7.50M(0.0%) |
| Sep 1999 | - | $1.90M(-5.0%) | $7.50M(+1.4%) |
| Jun 1999 | - | $2.00M(+17.6%) | $7.40M(+10.4%) |
| Mar 1999 | - | $1.70M(-10.5%) | $6.70M(+3.1%) |
| Dec 1998 | $6.60M(+15.8%) | $1.90M(+5.6%) | $6.50M(+4.8%) |
| Sep 1998 | - | $1.80M(+38.5%) | $6.20M(+3.3%) |
| Jun 1998 | - | $1.30M(-13.3%) | $6.00M(0.0%) |
| Mar 1998 | - | $1.50M(-6.3%) | $6.00M(+7.1%) |
| Dec 1997 | $5.70M(+54.1%) | $1.60M(0.0%) | $5.60M(-1.8%) |
| Sep 1997 | - | $1.60M(+23.1%) | $5.70M(+18.8%) |
| Jun 1997 | - | $1.30M(+18.2%) | $4.80M(+14.3%) |
| Mar 1997 | - | $1.10M(-35.3%) | $4.20M(+13.5%) |
| Dec 1996 | $3.70M | $1.70M(+142.9%) | $3.70M(+85.0%) |
| Sep 1996 | - | $700.00K(0.0%) | $2.00M(+53.8%) |
| Jun 1996 | - | $700.00K(+16.7%) | $1.30M(+116.7%) |
| Mar 1996 | - | $600.00K | $600.00K |
FAQ
- What is Neurocrine Biosciences annual SGA?
- What is the all time high annual SGA for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual SGA year-on-year change?
- What is Neurocrine Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly SGA year-on-year change?
- What is Neurocrine Biosciences TTM SGA?
- What is the all time high TTM SGA for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM SGA year-on-year change?
What is Neurocrine Biosciences annual SGA?
The current annual SGA of NBIX is $1.01B
What is the all time high annual SGA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual SGA is $1.01B
What is Neurocrine Biosciences annual SGA year-on-year change?
Over the past year, NBIX annual SGA has changed by +$119.60M (+13.47%)
What is Neurocrine Biosciences quarterly SGA?
The current quarterly SGA of NBIX is $276.50M
What is the all time high quarterly SGA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly SGA is $287.80M
What is Neurocrine Biosciences quarterly SGA year-on-year change?
Over the past year, NBIX quarterly SGA has changed by +$33.40M (+13.74%)
What is Neurocrine Biosciences TTM SGA?
The current TTM SGA of NBIX is $56.30M
What is the all time high TTM SGA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM SGA is $56.30M
What is Neurocrine Biosciences TTM SGA year-on-year change?
Over the past year, NBIX TTM SGA has changed by -$831.70M (-93.66%)